Pharmacological considerations in the modulation of multidrug resistance
Open Access
- 1 June 1996
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (6) , 1082-1088
- https://doi.org/10.1016/0959-8049(96)00111-6
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Expression Pattern of MRP in Human Tissues and Adult Solid Tumor Cell LinesJNCI Journal of the National Cancer Institute, 1995
- Multidrug resistance and the role of P-glycoprotein knockout miceEuropean Journal Of Cancer, 1995
- Effect of colchicine and heat shock on multidrug resistance gene and P-glycoprotein expression in rat liverJournal of Hepatology, 1994
- Selective inhibition of hepatic P-glycoprotein mediated excretion by SDZ PSC 833 and dexniguldipinAnti-Cancer Drugs, 1994
- Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primatesHepatology, 1993
- Multidrug resistance and mutagenesisMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1993
- Intermittent high-dose tamoxifen as a potential modifier of multidrug resistanceEuropean Journal Of Cancer, 1992
- Multiple-Drug Resistance in Human CancerNew England Journal of Medicine, 1987
- Daunomycin accumulation in resistant tumor cells as a screening model for resistance modifying drugs: Role of protein bindingCancer Letters, 1987
- The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humansAmerican Heart Journal, 1985